192 related articles for article (PubMed ID: 26908453)
21. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.
Knight JS; Sharma N; Kalman DE; Robertson ES
J Virol; 2004 Dec; 78(23):12857-67. PubMed ID: 15542638
[TBL] [Abstract][Full Text] [Related]
22. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.
Maruo S; Wu Y; Ishikawa S; Kanda T; Iwakiri D; Takada K
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19500-5. PubMed ID: 17159137
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation.
Ito K; Maruyama Z; Sakai A; Izumi S; Moriishi T; Yoshida CA; Miyazaki T; Komori H; Takada K; Kawaguchi H; Komori T
Oncogene; 2014 Apr; 33(14):1862-71. PubMed ID: 23624920
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro.
Chen A; Divisconte M; Jiang X; Quink C; Wang F
J Virol; 2005 Apr; 79(7):4506-9. PubMed ID: 15767450
[TBL] [Abstract][Full Text] [Related]
26. Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.
Renouf B; Hollville E; Pujals A; Tétaud C; Garibal J; Wiels J
Leukemia; 2009 Sep; 23(9):1557-63. PubMed ID: 19421231
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis.
Pokrovskaja K; Okan I; Kashuba E; L Wbeer M; Klein G; Szekely L
J Gen Virol; 1999 Apr; 80 ( Pt 4)():987-995. PubMed ID: 10211969
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
Tomkinson B; Robertson E; Kieff E
J Virol; 1993 Apr; 67(4):2014-25. PubMed ID: 8445720
[TBL] [Abstract][Full Text] [Related]
29. Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.
AlQarni S; Al-Sheikh Y; Campbell D; Drotar M; Hannigan A; Boyle S; Herzyk P; Kossenkov A; Armfield K; Jamieson L; Bailo M; Lieberman PM; Tsimbouri P; Wilson JB
Oncogene; 2018 Jul; 37(29):3998-4012. PubMed ID: 29691476
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor.
Sahu SK; Mohanty S; Kumar A; Kundu CN; Verma SC; Choudhuri T
Virology; 2014 Jan; 448():333-43. PubMed ID: 24314664
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.
Jha HC; A J MP; Saha A; Banerjee S; Lu J; Robertson ES
J Virol; 2014 Apr; 88(7):3776-88. PubMed ID: 24429368
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53.
Kashuba E; Yurchenko M; Yenamandra SP; Snopok B; Szekely L; Bercovich B; Ciechanover A; Klein G
Int J Cancer; 2011 Feb; 128(4):817-25. PubMed ID: 20473904
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
Skalska L; White RE; Franz M; Ruhmann M; Allday MJ
PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956
[TBL] [Abstract][Full Text] [Related]
35. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
Klein G; Klein E; Kashuba E
Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.
Maruo S; Wu Y; Ito T; Kanda T; Kieff ED; Takada K
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4419-24. PubMed ID: 19237563
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of
Gillman ACT; Parker G; Allday MJ; Bazot Q
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135119
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1.
Kaul R; Verma SC; Murakami M; Lan K; Choudhuri T; Robertson ES
J Virol; 2006 Feb; 80(3):1321-31. PubMed ID: 16415009
[TBL] [Abstract][Full Text] [Related]
39. EBV persistence without its EBNA3A and 3C oncogenes in vivo.
Murer A; McHugh D; Caduff N; Kalchschmidt J; Barros M; Zbinden A; Capaul R; Niedobitek G; Allday M; Chijioke O; Münz C
PLoS Pathog; 2018 Apr; 14(4):e1007039. PubMed ID: 29709016
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA.
Bain M; Watson RJ; Farrell PJ; Allday MJ
J Virol; 1996 Apr; 70(4):2481-9. PubMed ID: 8642676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
